Dr Robert Mahar
Senior Research Fellow - Biostats
Melbourne School of Population and Global Health
50 Scholarly works
6 Projects
HIGHLIGHTS
2026
Journal article
Testing interventions to increase participation in the Australian National Bowel Cancer Screening Program among persistent never-screeners: study protocol for a randomised controlled trial
DOI: 10.1186/s13063-026-09553-22026
Journal article
Inverse probability weighted estimation of dynamic treatment regimen means in sequential multiple assignment randomised trials with missing data: a simulation study
DOI: 10.1186/s13063-026-09493-x2026
Journal article
Prospective accuracy study on an artificial intelligence-based ultrasound system for gestational age estimation among pregnant women in Ghana, Kenya and South Africa: protocol
DOI: 10.1136/bmjopen-2026-1183302026
Journal article
Application of a Novel Desirability of Outcome Ranking Endpoint Incorporating a Framework for Resistance Assessment and Microbiologic Evaluation in Antibiotic Trials: A Proof-of-Concept in a Post Hoc Analysis of the BALANCE Trial
DOI: 10.1093/ofid/ofag1422025
Research grants (ARC, NHMRC, MRFF)
STReptococcal Adaptive Platform Trial (STRAP)
2024
Research grants (ARC, NHMRC, MRFF)
PLATIPUS: A Platform for Adaptive Trials in Perinatal Units
2022
Research grants (ARC, NHMRC, MRFF)
Tackling Australia\2019s Low Screening Participation to Prevent Bowel Cancer Morbidity and Deaths
RECENT SCHOLARLY WORKS
2026
Journal article
Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
DOI: 10.1056/NEJMoa25069052026
Journal article
Hierarchical composite endpoints provide a flexible framework to ensure clinical trials measure outcomes important to all stakeholders.
DOI: 10.1093/cid/ciag2772026
Journal article
Comparing different methods for analysing hierarchical composite endpoints: two illustrative case studies with post hoc analyses of the BALANCE (Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness) and CAMERA2 (Combination Antibiotics for methicillin-resistant Staphylococcus aureus) randomized clinical trials
DOI: 10.1016/j.cmi.2025.11.0272026
Journal article
Accounting for non-adherence to assigned antibiotic treatment duration for bloodstream infection (BALANCE): a post-hoc analysis of a randomised clinical trial
DOI: 10.1016/S1473-3099(25)00592-42026
Journal article
Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial
DOI: 10.1093/cid/ciaf4092025
Journal article
Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trial
DOI: 10.1186/s13063-024-08684-8
RECENT PROJECTS
2024
Research grants (ARC, NHMRC, MRFF)
OUTcomes POST COVID - Australian Platform Trial (OUTPOST-APT)
2022
Internal Research Grant
Getting SMART About Missing Data